All lobbying filings

Alston & Bird LLP

Alston & Bird LLP filed a Q1 report for Dexcom, Inc. on April 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Dexcom, Inc. · Medical Device manufacturing.

As filed: ALSTON & BIRD LLP for DEXCOM, INC.

All filings by Alston & Bird LLP · Everything Dexcom, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to coverage and reimbursement for continuous glucose monitors.

Medicare/Medicaid

Issues related to coverage and reimbursement for continuous glucose monitors.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.